Evidence map›Paper›PMID 33307419›Full record

ArticleInternational journal of pediatric otorhinolaryngology2021

Subtle olfactory dysfunction after SARS-CoV-2 virus infection in children.

Ana Concheiro-Guisan, Antía Fiel-Ozores, Reyes Novoa-Carballal, María Luisa González-Duran, Mar Portugués de la Red, Cristina Martínez-Reglero, Isabel Fernández-Pinilla, Isabel González-Guijarro

Open access · greenAbstract read
In one paragraph

Article in International journal of pediatric otorhinolaryngology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 5 pooled it
1.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 5 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Differences in pediatric SARS-CoV-2 symptomology and Co-infection rates among COVID-19 Pandemic waves.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2022
    Article
  8. Neurological effects of COVID-19 in infants and children.Developmental medicine and child neurology · 2022
    Review
  9. International consensus statement on allergy and rhinology: Olfaction.International forum of allergy & rhinology · 2022
    Review
  10. Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis.medRxiv : the preprint server for health sciences · 2021
    Article
  11. Clinical significance of olfactory dysfunction in patients of COVID-19.Journal of the Chinese Medical Association : JCMA · 2021
    Review
  12. Otolaryngology manifestations of COVID-19 in pediatric patients.International journal of pediatric otorhinolaryngology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ana Concheiro-GuisanDepartment of Paediatrics, Alvaro Cunqueiro University Hospital, Vigo, Spain. Electronic address: ana.concheiro.guisan@sergas.es.
Antía Fiel-OzoresDepartment of Paediatrics, Alvaro Cunqueiro University Hospital, Vigo, Spain.
Reyes Novoa-CarballalDepartment of Paediatrics, Alvaro Cunqueiro University Hospital, Vigo, Spain.
María Luisa González-DuranDepartment of Paediatrics, Alvaro Cunqueiro University Hospital, Vigo, Spain.
Mar Portugués de la RedDepartment of Paediatrics, Alvaro Cunqueiro University Hospital, Vigo, Spain.
Cristina Martínez-RegleroMethodology and Statistics Unit, Galicia Sur Health Research Institute (IISGS), Vigo, Spain.
Isabel Fernández-PinillaDepartment of Paediatrics, Alvaro Cunqueiro University Hospital, Vigo, Spain.
Isabel González-GuijarroDepartment of Otorhinolaryngology, Clinical University Hospital, Santiago de Compostela, Spain.
University Hospital Complex Of Vigo · ESUniversidade de Santiago de Compostela · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAnosmia/hyposomia have been described as early signs of COVID-19 infection in adults, including young asymptomatic patients who commonly refer olfactory disfunction as their only clinical manifestation. Very few studies involving paediatric age patients have been published until now. This study aims to determine the presence of olfactory dysfunction in children with COVID-19 infection through the use of a self-reported questionnaire and a new olfactory screening tool.

methodsNested case-control study. All paediatric patients screened by reverse transcription polymerase chain reaction (RT-PCR) and Anti-SARS-CoV-2 antibodies for COVID-19 infection, during the study period (March-May 2020), were asked to respond to a questionnaire about symptoms of olfactory disfunction. Patients above six years old also performed an odor identification test based on seven odorants (Kradeo®). This test was designed based on our cultural context and eating habits.

results126 patients were recruited, including 33 with COVID-19 infection. 15% of the infected children referred anosmia and/or dysgeusia on the questionnaire, all of them were older than eleven years. The results of the odor test (69 patients) revealed subtle disturbances in the infected group (mostly misrecognition of odorants). Median odorant recognition was 3 odors [Interquartile range (IQR) 2-4] in case group and 4 [IQR 3-5] in controls. Male patients showed significantly larger disturbances than girls in both groups (p = 0.03).

conclusionSelf-referred prevalence of olfactory disfunction in our sample of infected children is lower than that described in adults, especially among the youngest ones, maybe due to immature development of angiotensin-converting enzyme 2 (ACE2) receptors expressed in nasal mucosa. Nevertheless, one month after infection, subtle disturbances (misrecognition of odors) were identified among the infected children. This screening olfactory test provides a hygienic, user-friendly tool, suitable for screening children older than six years of age.

Indexed as

AdolescentCase-Control StudiesChildChild, PreschoolCOVID-19FemaleHumansInfantInfant, NewbornMaleOlfaction DisordersPrevalenceSARS-CoV-2SmellAnosmiaChildrenCOVID-19HyposomiaOdor testSARS-CoV-2 virus

Identifiers

PMID33307419
PMCPMC7706415
OpenAlexW3093900357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.